Minerva Neurosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. 

CEO
Rémy Henri Luthringer
CEORémy Henri Luthringer
Employees
9
Employees9
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
9
Employees9

NERV Key Statistics

Market cap
50.46M
Market cap50.46M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
460.47K
Average volume460.47K
High today
$9.78
High today$9.78
Low today
$8.71
Low today$8.71
Open price
$9.49
Open price$9.49
Volume
310.91K
Volume310.91K
52 Week high
$16.08
52 Week high$16.08
52 Week low
$2.51
52 Week low$2.51

NERV Earnings

-$4.00
-$2.67
-$1.33
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.